Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Naturewell, formerly known as Gum Tech International, was a pharmaceutical and nutraceutical company primarily known for developing the Zicam line of cold remedies. The company specialized in the development of homeopathic and natural health products delivered through unique delivery systems, such as nasal sprays and lozenges. Beyond its commercial success with zinc-based cold treatments, Naturewell pursued a clinical pipeline targeting migraine, arthritis, and diabetes using proprietary formulations. However, the company faced significant regulatory and legal challenges related to its flagship products, leading to the eventual divestiture of its core assets and cessation of operations. At its peak, it represented a significant player in the intersection of traditional pharmaceuticals and natural health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Naturewell.